ПРЕПАРАТЫ РАСТОРОПШИ: МЕХАНИЗМЫ ДЕЙСТВИЯ И ПРИМЕНЕНИЕ ПРИ ЗАБОЛЕВАНИЯХ ПЕЧЕНИ
https://doi.org/10.51523/2708-6011.2009-6-4-6
Аннотация
Препараты расторопши пятнистой обладают выраженными гепатопротекторными свойствами. В настоящее время рост интереса к данному лекарственному растению связан как с увеличением распространенности различных форм патологии печени, так и с открытием новых свойств его действующих компонентов. Предлагаемый обзор содержит информацию о фармакологии, механизме действия, эффективности применения препаратов расторопши при заболеваниях печени и демонстрирует возможности их использования при других патологических состояниях.
Об авторах
Ю. И. Брель
Гомельский государственный медицинский университет
Беларусь
Беларусь
А. Н. Лызиков
Гомельский государственный медицинский университет
Беларусь
Беларусь
Э. С. Питкевич
Гомельский государственный медицинский университет
Беларусь
Беларусь
Список литературы
1. Pharmacology of Silymarin / F. Fraschini [et al.] // Clin. Drug Invest. - 2002. - Vol. 22, № 1. - P. 51-65.
2. Silymarin treatment of viral hepatitis: a systematic review / K. E. Mayer [et al.] // Journal of Viral Hepatitis. - 2005. - Vol. 12. - P. 559-567.
3. Kren, V. Silybin And Silymarin - new effects and applications / V. Kren, D. Walterova // Biomed. Papers. - 2005. - Vol. 149, № 1. - P. 29-41.
4. Pharmacokinetic studies with silymarin in human serum and bile / D. Lorenz [et al.] // Methods Find. Exp. Clin. Pharmacol. - 1984. - Vol. 6, № 10. - P. 655-661.
5. Pradhan, S. C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine / S. C. Pradhan, C. Girish // Indian J. Med. Res. - 2006. - Vol. 124, № 5. - P. 491-504.
6. Effect of free radical scavengers on superoxide dismutase (SOD) enzyme in patients with alcoholic cirrhosis / J. Feher [et al.] // Acta Medica Hungarica. - 1988. - Vol. 45, № 3/4. - P. 265-276.
7. Silybin dihemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetaminophen on rat liver / R. Campos [et al.] // Planta Med. - 1989. - Vol. 55, № 5. - P. 417-419.
8. Sonnenbichler, J. Mechanism of action of silibinin. V. Effect of silibinin on the synthesis of ribosomal RNA, mRNA and tRNA in rat liver in vivo / J. Sonnenbichler, I. Zetl // Hoppe Seylers Z Physiol. Chem. - 1984. - Vol. 365, № 5. - P. 555-566.
9. Inhibition of Kupffer cells as an explanation for the hepatoprotective properties of silibinin / C. Dehmlow [et al.] // Hepatology. - 1996. - Vol. 24, № 4. - P. 749-754.
10. Selective inhibition of NF-kB activation by the flavonoid hepatoprotector silymarin in HepG2. Evidence for different activating pathways / C. Saliou [et al.] // FEBS Lett. - 1998. - Vol. 440. - P. 8-12.
11. Effects of silibinin and of a synthetic analogue on isolated rat hepatic stellate cells and myofibroblasts / E. C. Fuchs [et al.] // Arzneimittelforschung. - 1997. - Vol. 47, № 12. - P. 1383-1387.
12. Characterization of a transporting system in rat hepatocytes: studies with competitive and noncompetitive inhibitors of phalloidin transport / K. Munter [et al.] // Biochem. Biophys. Acta. - 1986. - Vol. 860, № 1. - P. 91-98.
13. Silymarin: potent inhibitor of cyclic AMP phosphodiesterase / H. P. Koch [et al.] // Methods Find. Exp. Clin. Pharmacol. - 1985. - Vol. 7, № 8. - P. 409-413.
14. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells / A. Tyagi [et al.] // Prostate. - 2002. - Vol. 153, № 3. - P. 211-217.
15. Antitumour activity of the silybin-phosphatidylcholine complex IdB 1016, against human ovarian cancer / D. Gallo [et al.] // Eur. J. Cancer. - 2003. - Vol. 39. - P. 2403-2410.
16. Anticancer potential of silymarin: from bench to bed side / R. Agarwal [et al.] // Anticancer Res. - 2006. - Vol. 26, № 6B. - P. 4457-4498.
17. The flavonoid silibinin decreases glucose-6-phosphate hydrolysis in perfused rat hepatocytes by an inhibitory effect on glucose-6-phosphatase / B. Guigas [et al.] // Cell Physio. Biochem. - 2007. - Vol. 20, № 6. - P. 925-934.
18. Skottova, N. Silymarin as a potential hypocholesterolaemic drug / N. Skottova, V. Kreeman // Physiol Res. - 1998. - Vol. 47. - P. 1-7.
19. Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation / M. J Wang [et al.] // Eur. J. Neurosci. - 2002. - Vol. 16. - P. 2103-2112.
20. Jung, H. J. Synergistic antibacterial effect between silybin and N,N'-dicyclohexylcarbodiimide in clinical Pseudomonas aeruginosa isolates / H. J. Jung, D. G. Lee // J. Microbiol. - 2008. - Vol. 46, № 4. - P. 462-467.
21. In vitro antimalarial activity of flavonoid derivatives dehydrosilybin and 8-(1;1)-DMA-kaempferide / De F. Monbrison [et al.] // Acta Trop. - 2006. - Vol. 97, № 1. - P. 102-107.
22. Ethanol elimination in man under influence of hepatoprotective silibinin / M. Varga [et al.] // Blutalkohol. - 1991. - Vol. 28, № 6. - P. 405-408.
23. Liver protective action of silymarin therapy in chronic alcoholic liver diseases / I. Feher [et al.] // Orv. Hetil. - 1989. - Vol. 130. - P. 2723-2727.
24. Salmi, H. A. Effects of silymarin on chemical, functional and morphological alterations of the liver. A double-blind controlled study / H. A. Salmi, S. Sarna // Scand. J. Gastroenterol. - 1982. - Vol. 17. - P. 517-521.
25. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis Results of a randomized, double-blind, placebo-controlled clinical study / M. I. Lucena [et al.] // Int. J. Clin. Pharmacol. Therapeut. - 2002. - Vol. 40, № 1. - P. 2-8.
26. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver / P. Ferenci [et al.] // J. Hepatol. - 1989. - Vol. 9, № 1. - P. 105-113.
27. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial / A. Pares [et al.] // J. Hepatol. - 1998. - Vol. 28, № 4. - P. 615-621.
28. Protection by silibinin against Amanita phalloides intoxication in beagles / G. Vogel [et al.] // Toxicol. Appl. Pharmacol. - 1984. - Vol. 73. - P. 355-362.
29. Treatment of amatoxin poisoning: 20-year retrospective analysis / F. Enjalbert [et al.] // J. Toxicol. Clin. Toxicol. - 2002. - Vol. 40, № 6. - P. 715-757.
30. Chemotherapy of Amanita phalloides poisoning with intravenous silibinin / K. Hruby [et al.] // Hum. Toxicol. - 1983. - Vol. 2, № 2. - P. 183-195.
31. Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres / E. Magliulo [et al.] // Med. Klin. - 1978. - Vol. 73, № 28/29. - P. 1060-1065.
32. Therapeutic effect of silipide in patients with chronic hepatitis C non-responders (NTs) to interferon (IFN) treatment / G. Buzzelli [et al.] // J. Hepatol. - 1994. - Vol.21, № 1. - P. 100.
33. A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronicactive hepatitis / G. Buzzelli [et al.] // Int. J. Clin. Pharmacol. Ther Toxicol. - 1993. - Vol. 31, № 9. - P. 456-460.
34. Randomized open study of the dose-effect relationship of a short course of IdB 1016 in patients with viral or alcoholic hepatitis / A. Vailati [et al.] // Fitoterapia. - 1993. - Vol. 64, № 3. - P. 219-228.
35. Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection / K. Falasca [et al.] // J. Med. Virol. - 2008. - Vol. 80, № 11. - P. 1900-1906.
Рецензия
Для цитирования:
Брель Ю.И., Лызиков А.Н., Питкевич Э.С. ПРЕПАРАТЫ РАСТОРОПШИ: МЕХАНИЗМЫ ДЕЙСТВИЯ И ПРИМЕНЕНИЕ ПРИ ЗАБОЛЕВАНИЯХ ПЕЧЕНИ. Проблемы здоровья и экологии. 2009;(4):36-42. https://doi.org/10.51523/2708-6011.2009-6-4-6
For citation:
Brel Y.I., Lyzikov A.A., Pitkevich E.S. HETRBAL PREPARATIONS FROM MILK THISTLE: MECHANISMS OF ACTION AND APPLICATION IN LIVER DISEASES. Health and Ecology Issues. 2009;(4):36-42. (In Russ.) https://doi.org/10.51523/2708-6011.2009-6-4-6
Просмотров: 296
Послать статью по эл. почте 